Tyrosine-like condensed derivatives as tyrosinase inhibitors

M.J. Matos, L. Santana, E. Uriarte, S. Serra, M. Corda, M.B. Fadda, B. Era, A. Fais

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives We report the pharmacological evaluation of a new series of 3-aminocoumarins differently substituted with hydroxyl groups, which have been synthesized because they include in their structures the tyrosine fragment (tyrosine-like compounds), with the aim of discovering structural features necessary for tyrosinase inhibitory activity. Methods The synthesized compounds 4 and 7-9 were evaluated in vitro as mushroom tyrosinase inhibitors. Key findings Two of the described compounds showed lower IC50 (concentration giving 50% inhibition of tyrosinase activity) than umbelliferone, used as a reference compound. Conclusions Compound 7 (IC50 = 53 μm) was the best tyrosinase inhibitor of this small series, having an IC50 value 10-fold lower than umbelliferone. Compound 7 (3-amino-7-hydroxycoumarin) had amino and hydroxyl groups precisely mimicking the same positions that both groups occupy on the tyrosine molecule.
Original languageEnglish
Pages (from-to)742-746
Number of pages5
JournalJournal of Pharmacy and Pharmacology
Volume64
Issue number5
DOIs
Publication statusPublished - 1 May 2012

Fingerprint Dive into the research topics of 'Tyrosine-like condensed derivatives as tyrosinase inhibitors'. Together they form a unique fingerprint.

Cite this